Related content

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population

By Scott Stuart A   Edelmann Lisa   Kornreich Ruth   Erazo Monica   Desnick Robert J  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 721-730

Future Medicine

Access to resources Recommend Favorite

Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians

By Borgiani Paola   Ciccacci Cinzia   Forte Vittorio   Romano Silvia   Federici Giorgio   Novelli Giuseppe  

Pharmacogenomics, Vol. 8, Iss. 11, 2007-11 ,pp. : 1545-1550

Future Medicine

Access to resources Recommend Favorite

Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity

By Dandara Collet   Lombard Zané   Du Plooy Ingrid   McLellan Tracy   Norris Shane A   Ramsay Michèle  

Pharmacogenomics, Vol. 12, Iss. 12, 2011-12 ,pp. : 1663-1670

Future Medicine

Access to resources Recommend Favorite

CYP2C9 genetic variants and losartan oxidation in a Turkish population

By Babaoglu Melih   Yasar Umit   Sandberg Mia   Eliasson Erik   Dahl Marja-Liisa   Kayaalp S.   Bozkurt Atila  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 5, 2004-07 ,pp. : 337-342

Springer Publishing Company

Access to resources Recommend Favorite

The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical Significance

By  

Current Clinical Pharmacology, Vol. 2, Iss. 1, 2007-01 ,pp. : 93-109

Bentham Science Publishers

Access to resources Recommend Favorite